Metformin is associated with improved survival in endometrial cancer

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 438-442

  Ko, Emily M ^d   Walter, Paige ^b   Jackson, Amanda ^a   Clark, Leslie ^a   Franasiak, Jason ^a   Bolac, Corey ^b   Havrilesky, Laura J ^b   Secord, Angeles Alvarez ^b   Moore, Dominic T ^c   Gehrig, Paola A ^a,c   Bae Jump, Victoria ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetes; Endometrial cancer; Metformin; Obesity

Indexed keywords

DIABETES; ENDOMETRIAL CANCER; METFORMIN; OBESITY;

AGED; COHORT STUDIES; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84894041491     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.11.021     Document Type: Article

References (36)

1. Society AC Cancer facts and figures 2013 2013 [Atlanta]
2. CDC National Diabetes Fact Sheet; National estimates and general information on diabetes and prediabetes in the United States 2011 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Atlanta, GA
3. CDC Overweight and obesity: data and statistics, adult obesity facts 2012 Centers for Disease Control and Prevention
4. E.M. Ko, P. Walter, L. Clark, L.J. Havrilesky, A. Alvarez Secord, and P.A. Gehrig et al. Redefining obesity, diabetes, and race in type I and type II endometrial cancers Oncologists SG Society of Gynecologic Oncologists Annual Meeting for Women's Cancer 2013 Society of Gynecologic Oncologists Los Angeles
5. A.N. Fader, L.N. Arriba, H.E. Frasure, and V.E. von Gruenigen Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship Gynecol Oncol 114 2009 121 127
6. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578
7. E. Friberg, N. Orsini, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of endometrial cancer: a meta-analysis Diabetologia 50 2007 1365 1374
8. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
9. V.E. von Gruenigen, C. Tian, H. Frasure, S. Waggoner, H. Keys, and R.R. Barakat Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study Cancer 107 2006 2786 2791
10. Y. Zhang, Z. Liu, X. Yu, X. Zhang, S. Lu, and X. Chen et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China Gynecol Oncol 117 2010 41 46
11. K.K. Ward, N.R. Shah, C.C. Saenz, M.T. McHale, E.A. Alvarez, and S.C. Plaxe Cardiovascular disease is the leading cause of death among endometrial cancer patients Gynecol Oncol 126 2012 176 179
12. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, and R. Sherwin et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 2009 193 203
13. A. Decensi, M. Puntoni, P. Goodwin, M. Cazzaniga, A. Gennari, and B. Bonanni et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis Cancer Prev Res (Phila) 3 2010 1451 1461
14. G.W. Landman, N. Kleefstra, K.J. van Hateren, K.H. Groenier, R.O. Gans, and H.J. Bilo Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 Diabetes Care 33 2010 322 326
15. G. Libby, L.A. Donnelly, P.T. Donnan, D.R. Alessi, A.D. Morris, and J.M. Evans New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes Diabetes Care 32 2009 1620 1625
16. I. Ben Sahra, Y. Le Marchand-Brustel, J.F. Tanti, and F. Bost Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9 2010 1092 1099
17. L.A. Cantrell, C. Zhou, A. Mendivil, K.M. Malloy, P.A. Gehrig, and V.L. Bae-Jump Metformin is a potent inhibitor of endometrial cancer cell proliferation - implications for a novel treatment strategy Gynecol Oncol 116 2010 92 98
18. E. Giovannucci, D.M. Harlan, M.C. Archer, R.M. Bergenstal, S.M. Gapstur, and L.A. Habel et al. Diabetes and cancer: a consensus report Diabetes Care 33 2010 1674 1685
19. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli Cellular and molecular mechanisms of metformin: an overview Clin Sci (Lond) 122 2012 253 270
20. C.J. Currie, C.D. Poole, S. Jenkins-Jones, E.A. Gale, J.A. Johnson, and C.L. Morgan Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival Diabetes Care 35 2012 299 304
21. N.S. Nevadunsky, A. Van Arsdale, H.D. Strickler, A. Moadel, G. Kaur, and M. Frimer et al. Metformin use and endometrial cancer survival Gynecol Oncol 2013 [Electronic publication ahead of print]
22. X. He, F.J. Esteva, J. Ensor, G.N. Hortobagyi, M.H. Lee, and S.C. Yeung Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2 + breast cancer Ann Oncol 23 2012 1771 1780
23. X.X. He, S.M. Tu, M.H. Lee, and S.C. Yeung Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients Ann Oncol 22 2011 2640 2645
24. J.H. Lee, T.I. Kim, S.M. Jeon, S.P. Hong, J.H. Cheon, and W.H. Kim The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus Int J Cancer 131 2012 752 759
25. I.L. Romero, A. McCormick, K.A. McEwen, S. Park, T. Karrison, and S.D. Yamada et al. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity Obstet Gynecol 119 2012 61 67
26. S.L. Bowker, S.R. Majumdar, P. Veugelers, and J.A. Johnson Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 2006 254 258
27. C.J. Currie, J.R. Peters, A. Tynan, M. Evans, R.J. Heine, and O.L. Bracco et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study Lancet 375 2010 481 489
28. C.J. Currie, C.D. Poole, and E.A. Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 2009 1766 1777
29. A.A. Onitilo, J.M. Engel, I. Glurich, R.V. Stankowski, G.M. Williams, and S.A. Doi Diabetes and cancer II: role of diabetes medications and influence of shared risk factors Cancer Causes Control 23 2012 991 1008
30. S. Suissa, and L. Azoulay Metformin and the risk of cancer: time-related biases in observational studies Diabetes Care 35 2012 2665 2673
31. K.J. Dedes, D. Wetterskog, A. Ashworth, S.B. Kaye, and J.S. Reis-Filho Emerging therapeutic targets in endometrial cancer Nat Rev Clin Oncol 8 2011 261 271
32. P.A. Gehrig, and V.L. Bae-Jump Promising novel therapies for the treatment of endometrial cancer Gynecol Oncol 116 2010 187 194
33. R.K. Hanna, C. Zhou, K.M. Malloy, L. Sun, Y. Zhong, and P.A. Gehrig et al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway Gynecol Oncol 125 2012 458 469
34. K.M. Schuler, B.S. Rambally, M.J. Difurio, P.A. Gehrig, and V. Bae-Jump A preoperative window study of metformin for the treatment of endometrial cancer Oncology ASoC American Society of Clinical Oncology 2013 Annual Meeting Chicago, IL: Journal of Clinical Oncology 2013 [p. suppl; abstr 5519]
35. P.T. Soliman, R. Broaddus, S. Westin, D. Iglesias, M. RMunsell, and R. Schmandt et al. Phase 0 study: prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer Society of Gynecologic Oncologists Annual Meeting on Women's Cancer 2013 Society of Gynecologic Oncologists Los Angeles S15
36. E.M. Ko, J. Franasiak, K. Sink, W.R. Brewster, P.A. Gehrig, and V. Bae-Jump Obesity, diabetes, and race in Type 1 and Type 2 endometrial cancers J Clin Oncol 29 2011 [Suppl.; abstr 5111]